Funding for this research was provided by:
Canada Foundation for Innovation (11358)
Ontario Institute for Cancer Research (Clinician-Scientist Grant)
Received: 11 June 2020
Accepted: 8 January 2021
First Online: 13 January 2021
Ethics approval and consent to participate
: Institutional Research Ethics Board approval was obtained from Lawson Health Research Institute prior to study initiation, and the study was centrally registered (NCT02136355).
: All authors consented to the publication of the manuscript.
: The CT Perfusion software is licensed to GE Healthcare (TYL).